Summit Financial’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,484
Closed -$234K 1409
2025
Q4
$234K Buy
35,484
+10,392
+41% +$40.5K ﹤0.01% 1177
2025
Q3
$77.3K Buy
+25,092
New +$72.2K ﹤0.01% 1225

Other funds holding CALC

Summit Financial's CALC Position: Q1 2026 in Review

Summit Financial sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 35,484 shares — an estimated $234K sold.

Summit Financial first reported a position in CALC in Q3 2025 and held it in 2 quarters. The position peaked at $234K in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • Summit Financial reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
  • Summit Financial sold 35,484 CalciMedica shares in Q1 2026, an estimated $234K.
  • Summit Financial first reported a position in CalciMedica in Q3 2025 and held it in 2 quarters.
  • Summit Financial's CalciMedica position peaked at $234K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.